BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors
NCT02171676 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2014-06-24
Summary
Maximum tolerated dose (MTD), safety, pharmacokinetic and pharmacodynamic parameters, and efficacy of pulsatile administration of BIBW 2992 in combination with docetaxel (Taxotere®)
Conditions
- Neoplasms
Interventions
- DRUG
- DRUG
-
BIBW 2992
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2008-03-31
More Related Trials
-
BIBW 2992 in Patients With Advanced Solid Tumors
NCT02171650 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors
NCT00730821 ·Status: COMPLETED ·Phase: PHASE1
-
BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit
NCT02211872 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
NCT02952248 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.
NCT00998296 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit
NCT02211859 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
NCT02138812 ·Status: TERMINATED ·Phase: PHASE1
-
An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours
NCT02182206 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of LB-100 With Docetaxel in Solid Tumors
NCT01837667 ·Status: COMPLETED ·Phase: PHASE1
-
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours
NCT04889599 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel
NCT01251653 ·Status: COMPLETED
-
PTC299 for Treatment of Advanced Cancer
NCT00704821 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors
NCT05213767 ·Status: UNKNOWN ·Phase: PHASE1
-
Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types
NCT01317420 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
NCT01206816 ·Status: COMPLETED ·Phase: PHASE1
-
BIBX 1382 in Treating Patients With Solid Tumors
NCT00003980 ·Status: SUSPENDED ·Phase: PHASE1
-
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
NCT01325441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1a/1b BGB-290 for Advanced Solid Tumors.
NCT02361723 ·Status: COMPLETED ·Phase: PHASE1
-
Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors
NCT00618735 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
NCT03166631 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
NCT05327946 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of XL820 in Adults With Solid Tumors
NCT00129571 ·Status: COMPLETED ·Phase: PHASE1
-
SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
NCT00169520 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors
NCT07124117 ·Status: RECRUITING ·Phase: PHASE1/PHASE2